## Investigation of Choice for Suspected Breast Carcinoma ### Clinical Context The patient presents with a **palpable, firm, fixed breast mass with skin dimpling** — classic features of malignancy. The clinical suspicion is high, and histological diagnosis is required. ### Why Core Needle Biopsy (CNB) is the Gold Standard **Key Point:** Core needle biopsy under ultrasound or mammographic guidance is the **investigation of choice** for diagnosis of palpable and non-palpable breast masses when malignancy is suspected. **High-Yield:** CNB provides: - **Tissue diagnosis** (histology, not just cytology) - **Architectural assessment** (invasive vs. in situ, grade, type) - **Immunohistochemistry capability** (ER/PR/HER2 status for prognostic and therapeutic planning) - **High sensitivity (95–98%) and specificity (99%)** - **Lower inadequacy rate** than FNAC ### Comparison of Diagnostic Modalities | Investigation | Tissue Type | Diagnostic Yield | Architectural Info | IHC Possible | Role | |---|---|---|---|---|---| | **FNAC** | Cells only | 80–90% | No | No | Screening; high false negatives | | **Core Needle Biopsy** | Tissue core | 95–98% | Yes | Yes | **Gold standard for diagnosis** | | **Mammography** | Imaging | N/A | No | No | Screening; characterization; not diagnostic | | **MRI** | Imaging | N/A | No | No | Problem-solving; not first-line diagnostic | ### Clinical Pearl In this patient with a **palpable, suspicious mass**, ultrasound-guided CNB is preferred over mammography-guided CNB because: - Real-time visualization of the mass and needle trajectory - Faster, less painful - No radiation exposure - Equally accurate **Warning:** FNAC is **not adequate** for diagnosis of breast carcinoma because it cannot assess architecture (invasive vs. in situ) and has higher false-negative rates. It is useful only for cystic lesions or as a triage tool in resource-limited settings. ### Algorithm for Palpable Breast Mass ```mermaid flowchart TD A[Palpable breast mass]:::outcome --> B{Clinical suspicion high?}:::decision B -->|Yes| C[Ultrasound assessment]:::action C --> D{Mass characteristics?}:::decision D -->|Solid, suspicious| E[Core Needle Biopsy]:::action D -->|Cystic| F[Aspiration/Observation]:::action E --> G[Histology + IHC]:::outcome G --> H[Diagnosis & Staging]:::outcome B -->|Low| I[Reassurance + Follow-up]:::action ``` **Key Point:** Tissue diagnosis (CNB) is **mandatory** before any treatment decision in suspected breast carcinoma.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.